CIK 1880124
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2023-Q2. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Unclassified | 83.69% | 9 |
| Pharmaceuticals & Biotechnology | 16.31% | 3 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | Unclassified | 42.74% | |
| 2 | AEROVATE THERAPEUTICS INC | Unclassified | 18.43% | |
| 3 | CYTEIR THERAPEUTICS INC | Unclassified | 15.71% | |
| 4 | PMVP | PMV Pharmaceuticals, Inc. | Health Care | 13.66% |
| 5 | GRAPHITE BIO INC | Unclassified | 2.27% | |
| 6 | SELECTA BIOSCIENCES INC | Unclassified | 2.06% | |
| 7 | VOR | Vor Biopharma Inc. | Health Care | 1.79% |
| 8 | EFFECTOR THERAPEUTICS INC | Unclassified | 1.38% | |
| 9 | DTIL | PRECISION BIOSCIENCES INC | Health Care | 0.86% |
| 10 | SPRO | SPERO THERAPEUTICS INC | Unclassified | 0.68% |
3/12 names classified · sector 16.3% of weight · industry 16.3% · mkt cap 16.3%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 16.3% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/5 names) · unclassified 100.0%: , PMVP, VOR, DTIL, SPRO. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | 2,937,615 | $19M | 42.7% | HOLD |
| 2 | AEROVATE THERAPEUTICS INC | 603,762 | $8M | 18.4% | HOLD |
| 3 | CYTEIR THERAPEUTICS INC | 2,459,572 | $7M | 15.7% | HOLD |
| 4 | PMVPPMV PHARMACEUTICALS INC | 989,232 | $6M | 13.7% | HOLD |
| 5 | GRAPHITE BIO INC | 406,308 | $1M | 2.3% | HOLD |
| 6 | SELECTA BIOSCIENCES INC | 862,543 | $914,296 | 2.1% | HOLD |
| 7 | VORVOR BIOPHARMA INC | 374,714 | $794,394 | 1.8% | HOLD |
| 8 | EFFECTOR THERAPEUTICS INC | 1,025,697 | $615,316 | 1.4% | HOLD |
| 9 | DTILPRECISION BIOSCIENCES INC | 1,123,913 | $383,592 | 0.9% | HOLD |
| 10 | SPROSPERO THERAPEUTICS INC | 249,070 | $301,375 | 0.7% | HOLD |
| 11 | IKENA ONCOLOGY INC | 26,833 | $116,187 | 0.3% | NEW |
| 12 | TRANSPORTATION & LOGISTI | 64,000 | $74,880 | 0.2% | HOLD |
Where this firm's principals came from and which firms its alumni went on to found.
